These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7738400)

  • 1. Cytokines and dermal papilla function in alopecia areata.
    McDonagh AJ; Elliott KR; Messenger AG
    J Invest Dermatol; 1995 May; 104(5 Suppl):9S-10S. PubMed ID: 7738400
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata.
    Norris DA; Duke R; Whang K; Middleton M
    J Invest Dermatol; 1995 May; 104(5 Suppl):8S-9S. PubMed ID: 7738399
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the dermal papilla a primary target in alopecia areata?
    Randall VA; Hull SP; Nutbrown M; Calver NS; Parkin SM; Cunliffe WJ
    J Invest Dermatol; 1995 May; 104(5 Suppl):7S-8S. PubMed ID: 7738398
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
    van Baar HM; Perret CM; van Vlijmen IM; van de Kerkhof PC; Happle R; Schalkwijk J
    Acta Derm Venereol; 1992; 72(3):161-4. PubMed ID: 1357847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to hair follicles in alopecia areata.
    Tobin DJ; Bystryn JC
    J Invest Dermatol; 1995 May; 104(5 Suppl):13S-14S. PubMed ID: 7738373
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata.
    Hull SM; Nutbrown M; Pepall L; Thornton MJ; Randall VA; Cunliffe WJ
    J Invest Dermatol; 1991 May; 96(5):673-81. PubMed ID: 1827135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor repertoire V beta in alopecia areata.
    Szafer F; Price VH; Oksenberg JR; Steinman L
    J Invest Dermatol; 1995 May; 104(5 Suppl):22S-24S. PubMed ID: 7738379
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
    Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
    J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased lymphocyte reactivity and auto-immunity in alopecia areata.
    Friedmann PS
    Br J Dermatol; 1981 Aug; 105(2):145-51. PubMed ID: 6974565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to hair follicles in alopecia areata.
    Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
    J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-DR in hair follicles in alopecia areata.
    Messenger AG; Bleehen SS; Slater DN; Rooney N
    Lancet; 1984 Aug; 2(8397):287-8. PubMed ID: 6146835
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-2 receptor alpha-chain expression in patients with alopecia areata.
    Brajac I; Gruber F; Petrovecki M; Malnar-Dragojević D
    Acta Dermatovenerol Croat; 2004; 12(3):154-6. PubMed ID: 15369638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 interferon signature in the scalp lesions of alopecia areata.
    Ghoreishi M; Martinka M; Dutz JP
    Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HLA-DR by anagen hair follicles in alopecia areata.
    Messenger AG; Bleehen SS
    J Invest Dermatol; 1985 Dec; 85(6):569-72. PubMed ID: 2415641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of T6 antigen on keratinocytes in alopecia areata.
    Lotti T; Knoepfel B; Zangheri M; Panconesi E
    Int J Dermatol; 1992 Feb; 31(2):103-6. PubMed ID: 1559731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
    Sato-Kawamura M; Aiba S; Tagami H
    Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Morohashi M; Takeuchi S; Sato Y
    Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin expression in alopecia areata hair follicles.
    Van Baar HM; Van Vlijmen IM; Ramaekers FC; Van Muijen GN; Troyanovsky SM; Perret CM; Van de Kerkhof PC; Schalkwijk J
    Acta Derm Venereol; 1994 Jan; 74(1):28-32. PubMed ID: 7511864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.